COM:ACURAPHARM

Acura Pharmaceuticals, Inc.

Stock

USD

Market Cap

303.61K

Beta: -

Volume Today

12K

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-13.21M -	-4.99M 62.23%	-7.39M 48.09%	-5.68M 23.09%	-3.84M 32.38%	-3.77M 1.77%	-1.21M 67.99%	-879K 27.24%
depreciation and amortization	274K -	332K 21.17%	345K 3.92%	294K 14.78%	280K 4.76%	273K 2.50%	125K 54.21%	90K 28.00%
deferred income tax	447K -	740K 65.55%	237K 67.97%	47K 80.17%	-296K 729.79%	2.60M 978.72%
stock based compensation	890K -	606K 31.91%	588K 2.97%	464K 21.09%	218K 53.02%	108K 50.46%	36K 66.67%	58K 61.11%
change in working capital	366K -	-563K 253.83%	510K 190.59%	268K 47.45%	-183K 168.28%	121K 166.12%	-340K 380.99%	477K 240.29%
accounts receivables	118K -	-69K 158.47%	19K 127.54%	23K 21.05%		44K -	-399K 1,006.82%	469K 217.54%
inventory	-254K -	-302K 18.90%	-59K 80.46%	103K 274.58%		-44K -	399K 1,006.82%	-469K 217.54%
accounts payables	-57K -	-107K 87.72%	-33K 69.16%	-74K 124.24%	602K 913.51%	-368K 161.13%	-206K 44.02%	161K 178.16%
other working capital	559K -	-85K 115.21%	583K 785.88%	216K 62.95%	-785K 463.43%	489K 162.29%	-134K 127.40%	316K 335.82%
other non cash items	188K -	186K 1.06%	145K 22.04%	99K 31.72%	-85K 185.86%	53K 162.35%	668K 1,160.38%	-488K 173.05%
net cash provided by operating activities	-11.04M -	-3.69M 66.61%	-5.56M 50.84%	-4.51M 18.93%	-3.91M 13.35%	-618K 84.19%	-719K 16.34%	-742K 3.20%
investments in property plant and equipment	-2.13M -	-214K 89.98%	-75K 64.95%
acquisitions net	2M -
purchases of investments	-2.20M -	-3.52M 59.87%
sales maturities of investments	4.34M -	3.83M 11.67%	10.87M 183.89%
other investing activites	-2M -	14K 100.70%		309K -
net cash used for investing activites	-2K -	108K 5,500%	10.80M 9,898.15%	309K 97.14%
debt repayment		-1.96M -	-2.54M 29.59%	-2.76M 8.66%	-2.57M 6.78%	-1.38M 46.56%	-269K 80.44%	-17K 93.68%
common stock issued	1K -	7.86M 786,100%		4M -	2K 99.95%	14K 600%	3K 78.57%	3K 0%
common stock repurchased							-2 -	-8 300%
dividends paid							-269.00K -	-8 100.00%
other financing activites	-521K -	-611K 17.27%	1K 100.16%		4.35M -	2.75M 36.78%	805K 70.73%	408.02K 49.31%
net cash used provided by financing activities	-520K -	5.29M 1,117.50%	-2.54M 147.99%	1.24M 148.84%	1.78M 43.47%	1.39M 21.92%	270K 80.56%	394K 45.93%
effect of forex changes on cash
net change in cash	-11.57M -	1.71M 114.79%	2.70M 57.57%	-2.96M 209.83%	-2.13M 28.10%	771K 136.21%	-449K 158.24%	-348K 22.49%
cash at beginning of period	12.34M -	774K 93.73%	2.48M 221.06%	5.18M 108.49%	2.22M 57.15%	91K 95.90%	862K 847.25%	413K 52.09%	65K 84.26%
cash at end of period	774K -	2.48M 221.06%	5.18M 108.49%	2.22M 57.15%	91K 95.90%	862K 847.25%	413K 52.09%	65K 84.26%	65K 0%
operating cash flow	-11.04M -	-3.69M 66.61%	-5.56M 50.84%	-4.51M 18.93%	-3.91M 13.35%	-618K 84.19%	-719K 16.34%	-742K 3.20%
capital expenditure	-2.13M -	-214K 89.98%	-75K 64.95%
free cash flow	-13.18M -	-3.90M 70.39%	-5.64M 44.49%	-4.51M 20.01%	-3.91M 13.35%	-618K 84.19%	-719K 16.34%	-742K 3.20%

All numbers in USD (except ratios and percentages)